Clinical Research

Clinical Research

Overview of the Clinical Research Program
at Eisenhower Desert Cardiology


The physicians of Eisenhower Desert Cardiology have been actively involved in conducting clinical research since the mid-1990s.  The program has grown exponentially since its inception and we are highly sought after as a research site by pharmaceutical, medical device and biotechnology companies. Eisenhower Desert Cardiology has also participated in several prestigious NIH-funded studies.  Participation in research offers advantages to patients, physicians, and the community.  Our cardiologists are knowledgeable of, and able to offer the most cutting edge therapeutic and diagnostic treatment options.

A number of the clinical staff at Eisenhower Desert Cardiology functions as coordinators for studies.  Our nurse practitioners, physician assistants, nurses from the Glickman Heart Failure Clinic, and staff from clinical areas throughout the hospital have all participated in conducting trials.  Eisenhower Desert Cardiology has a full-time certified clinical research professional - RN for the past eight years, as well as an assistant coordinator.  Every physician who participates as an investigator is required to maintain a certification in the Protection of Human Subjects and have knowledge of good clinical practice and the ICH guidelines.

Our patients may be requested to participate in an ongoing study if their Eisenhower Desert Cardiology physician feels it is in their best interest and if the inclusion/exclusion criteria for the study are met.  The physicians and research staff are available to explain the study and provide answers to your study questions anytime.
 
All studies must be approved by the Institutional Review Board of Eisenhower Medical Center and follow HIPAA regulations for privacy.  Participation is voluntary.

Please see below for a brief overview of some of the studies we are/have participated in over the last five years.  It encompasses the broad range of cardiology, including the electrophysiology procedures, cardiac catheterization procedures, cardiac medication, heart failure, nuclear imaging and health data registries.
 

CURRENT CLINICAL RESEARCH STUDIES

MIRACLE EF
Evaluate a market release CRT-P device in symptomatic heart failure patients with less severe LV dysfunction (EF 36% - 50%)  to support expansion of CRT indication globally. Five-year plus follow-up.

 Principal Investigator: Leon A. Feldman, MD
 Sub-Investigator: Andrew M. Rubin, MD
 Sponsor: MEDTRONIC
 Enrollment Status: OPEN

ABSORB III RCT
IDE Study to evaluate the safety and effectiveness of the Abbott Vascular Absorb Bioresorbable Vascular Scaffold System.  Patients are randomized to either the study scaffold or XIENCE stent. Five-year follow-up.

Principal Investigator: Khoi M. Le MD
Sub-Investigators: Puneet K. Khanna, MD, Andrew D. Frutkin, MD, Barry T. Hackshaw, MD
Sponsor: ABBOTT VASCULAR
Enrollment Status: OPEN

ProMRI
Study to confirm MRI safety of Entovis pacemaker and Sertrox S Pacing Leads. Study subject will undergo MRI of brain and lumbar after leads are healed into place. 3 month follow-up.

Principal Investigator: Leon A. Feldman, MD
Sub-Investigator: Andrew M. Rubin, MD
Sponsor: BIOTRONIK
Enrollment Status: OPEN

INGEVITY
IDE study to evaluate the safety, performance and effectiveness of the INGEVITY Active and Passive Fixation Pace/Sense Leads, five-year follow-up.

Principal Investigator: Andrew M. Rubin, MD
Sub-Investigator: Leon A. Feldman, MD
Sponsor: BOSTON SCIENTIFIC
Enrollment Status: OPEN

CELESTIAL
Post-approval registry to confirm long-term safety and reliability of the Corox OTW BP LV lead as used in conjunction with any  BIOTRONIK CRT-D or CRT-P, from implant through five years.

Principal Investigator:  Leon A. Feldman, MD
Sub-Investigator: Andrew M. Rubin, MD
Sponsor: BIOTRONIK
Enrollment Status:  OPEN

CHOCOLATE BAR
To collect data from real-world use with the Chocolate PTA Balloon Catheter to support the effectiveness of Chocolate in achieving optimal percutaneous transluminal angioplasty (PTA) procedural outcomes and to assess potential longer-term clinical benefits. 

Principal Investigator:  Puneet K. Khanna, MD     
Sub-Investigator:  Khoi M. Le, MD 
Sponsor:  TRIREME MEDICAL, INC.      
Enrollment Status: OPEN

GLORIA AF - PHASE II
GLORIA-AF Phase II/III is part of a global, multi-center, prospective Registry Program investigating patients with newly diagnosed non-valvular AF at risk for stroke (defined as a CHA2DS2-VASc stroke risk score of at least 1).

Principal Investigator:  Andrew M. Rubin, MD
Sub-Investigator:  Leon A. Feldman, MD
SPONSOR: BOEHRINGER INGELHEIM      
Enrollment Status: OPEN

LSR of Acuity Spiral
Evaluate long term reliability and clinical performance of Boston Scientific
ACUITY Spiral Lead.  Evaluated by a chronic LV lead-related complication-free
rate over 5 year follow-up.

Principal Investigator:  Leon A. Feldman, MD
Sub-Investigator:  Andrew M. Rubin, MD
Sponsor:  BOSTON SCIENTIFIC
Enrollment Status:  OPEN

PSR - Product Surveillance Registry
All studies integrated into the PPP provide ongoing information on the acute and chronic performance of Medtronic market-released cardiac therapy products.

Principal Investigator:  Andrew M. Rubin, MD
Sub-Investigator:  Leon A. Feldman, MD
Sponsor:  MEDTRONIC
Enrollment Status:  OPEN
 

CURRENT CLINICAL RESEARCH STUDIES (NOT ENROLLING)
IN FOLLOW UP ONLY

ORBIT II
Pivotal study to evaluate the safety and performance of Orbital Atherectomy
System in treating de novo, severely calcified coronary lesions.

Principal Investigator:  Puneet K. Khanna, MD
Sub-Investigator:  Barry T. Hackshaw, MD, Khoi M. Le, MD, Andrew D. Frutkin, MD
Sponsor:  CARDIOVASCULAR SYSTEMS, INC.
Enrollment Status:  FOLLOW-UP

ACCENT MRI
The intent of this IDE study is to evaluate the safety and efficacy of the implanted Accent MRITM system, which includes the investigational St. Jude Medical Tendril MRITM lead and Accent MRITM DR pacemaker, in and out of the MRI environment.

Principal Investigator: Andrew M. Rubin, MD
Sub-Investigator:   Leon A. Feldman, MD,Damon E. Kelsay, MD
Sponsor: ST JUDE
Enrollment Status:  FOLLOW UP

GALAXY
Post market registry to confirm long term safety and reliability of BIOTRONIK ICD leads as used in conjunction with any BIOTRONIK ICD pulse generator.

Principal Investigator:  Andrew M. Rubin, MD
Sub-Investigator: Leon A. Feldman, MD
Sponsor: BIOTRONIK
Enrollment Status:  FOLLOW-UP

RECENTLY CLOSED CLINICAL RESEARCH STUDIES

XIENCE V USA/DAPT
Registry to evaluate XIENCE V EECSS continued safety and effectiveness during commercial use in real world settings.  If there are no events in first year post stent deployment, patient to enter Dual Anti-Platelet Therapy sub-study.

Principal Investigator:  Barry T. Hackshaw, MD
Sub-Investigator:  Khoi M. Le, MD, Puneet K. Khanna, MD
Sponsor: ABBOTT
Enrollment Status:  CLOSED
 

EchoCRT
Demonstrate whether Cardiac Resynchronization Therapy (CRT=ON) in heart failure patients with narrow QRS complex and echo evidence of ventricular dyssynchrony will significantly reduce the combined endpoint of all-cause mortality or first hospitalization for worsening heart failure when compared to CRT=OFF.

Principal Investigator:  Leon A. Feldman, MD/Philip J. Patel, MD
Sub-Investigator: Andrew M. Rubin, MD
Sponsor: BIOTRONIK
Enrollment Status: CLOSED

ARISTOTLE STUDY
Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation.

Primary Investigator:  Andrew M. Rubin, MD
Sub-Investigator: Leon A. Feldman, MD
Sponsor: BRISTOL MYERS SQUIBB
Enrollment Status: CLOSED

BRADYCARE
Observational study to gain better understanding of how diagnostic capabilities in the Accent/Athem pacemakers are being utilized to manage patient care.

Principal Investigator: Andrew M. Rubin, MD
Sub-Investigator: Leon A. Feldman, MD
Sponsor:  ST> JUDE MEDICAL
Enrollment Status: CLOSED

DEFINITIVE LE
Study of SilverHawk device in the treatment of atherosclerotic femoropopliteal and tibioperoneal arteries - peripheral vascular disease.

Principal Investigator:  Puneet K. Khanna, MD
Sub-Investigator: Khoi M. Le, MD
Sponsor: EV3
Enrollment Status:  CLOSED

MADIT - RIT
To determine whether dual chamber ICD or CRT-D devices programmed with high-rate cutoff and/or long delay will be associated with fewer patients who experience inappropriate ATP or shock therapies when compared to standard programming during the first year of post-implant follow up of patients with indication of primary prevention device therapy.

Principal Investigator:  Leon A. Feldman, MD
Sub-Investigator:  Andrew M. Rubin, MD
Sponsor:  UNICERSITY OF ROCHESTER/BOSTON SCIENTIFIC
Enrollment Status:  CLOSED

 

/body.cfm|54.243.23.129||UA-85218-1